Is Chemours a Buy?
The top titanium dioxide manufacturer has seen its shares tumble. Is it now a bargain?
Chemours
CC
CC
$15.22
-$0.50
-3.2%
BATS BZX Real Time Price as of October 22, 2019, 10:09 a.m. EDT
View Interactive CC Charts
Chemours Company (The)
News & Analysis: Chemours
The Fool has written over 100 articles on Chemours.
Here's Why Chemours Stock Fell 20.5% in July
Investors were anticipating weak second-quarter 2019 operating results. They were right.
The Chemours Company (CC) Q2 2019 Earnings Call Transcript
CC earnings call for the period ending June 30, 2019.
Here's Why Chemours Tumbled 41.4% in May
The materials science company reported weak quarterly results, but environmental pollution risks are also piling up.
Why PetMed Express, Chemours, and Affiliated Managers Group Slumped Today
Earnings, analysts, and other concerns hurt these stocks.
The Chemours Company (CC) Q1 2019 Earnings Call Transcript
CC earnings call for the period ending March 31, 2019.
Is Chemours Company a Buy?
The chemical company's shares were way down...then way up. Is there still room to outperform?
The Chemours Company (CC) Q4 2018 Earnings Conference Call Transcript
CC earnings call for the period ending December 31, 2018.
The Chemours Company (CC) Q4 2018 Earnings Conference Call Transcript
CC earnings call for the period ending December 31, 2018.
Here's Why Chemours Stock Gained 26.7% in January
Investors gave the chemicals firm a fresh look after a miserable performance in 2018.
